EIF2AK3 and hepatocellular carcinoma: The results showed that G1896A mutation induced the activation of UPR signaling pathway in HCC cells, which was represented by increased protein expression of BIP, X‐box binding protein 1 (XBP1), ATF4 and ATF6, and phosphorylation of PERK and IRE1α (Figure 2C).